D09.19

Clinical Causes: Genetic mutations that alter cell growth and division Chronic inflammation or irritation of the urinary tract lining History of exposure to certain chemicals or carcinogens Smoking, which increases the risk of urinary tract cancers Chronic urinary infections that may contribute to cellular mutations

Key Symptoms: Hematuria (blood in urine), often painless Frequent urination or a persistent urge to urinate Pain or burning sensation during urination Unexplained pelvic or flank pain Urinary retention or difficulty urinating (less common in early stages)

Diagnosis Path: Diagnosis of carcinoma in situ in the urinary organs involves a combination of diagnostic procedures tailored to detect abnormal cellular changes that are confined to the lining. These include: - **Urinalysis:** To check for blood, infection, or abnormal cells in the urine. - **Cystoscopy:** A specialized endoscopic examination that allows direct visualization of the urinary tract lining for suspicious lesions. - **Biopsy:** Tissue samples obtained during cystoscopy are examined microscopically to confirm CIS. - **Imaging tests:** Such as ultrasound, CT scans, or MRI to evaluate the extent of the area involved and rule out invasive disease. - **Urine cytology:** Microscopic examination of urine cells to detect cancerous changes.

Treatment Protocols: Treatment strategies focus on removing or destroying abnormal cells to prevent progression. Options include: - **Transurethral resection of bladder tumor (TURBT):** A procedure that removes CIS lesions via cystoscopy. - **Intravesical therapy:** Instillation of therapeutic agents directly into the bladder, such as immunotherapy (e.g., Bacillus Calmette-Guerin or BCG) or chemotherapy. - **Regular monitoring:** Follow-up cystoscopies and urine tests to detect recurrence or progression. - **Potential future treatments:** Emerging therapies aimed at targeting early-stage cancer cells with minimal invasiveness. In some cases, additional treatments might be necessary depending on the extent and response to initial therapy. A healthcare professional will tailor the management plan based on individual diagnosis and risk factors.